The Digital Apothecary

JANUARY 23, 2021

I have served as an academic for the past eight years as an assistant and now associate professor of pharmacy practice, and during this time, my primary concern has been getting health professionals into digital health. It goes without saying it has been an uphill battle, and only in the past 12-24 months have I finally seen significant traction, primarily due to the ongoing Covid-19 Pandemic.

Inpatient 130

Inpatient Communication 130

pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. ‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literall

Documentation 143

Documentation Drug Development 143

NY Times

JANUARY 26, 2021

President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.

Vaccines 124

Vaccines Immunity Immunization 124

Pharma Times

JANUARY 25, 2021

The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually.

122

122

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

JANUARY 25, 2021

Two leaders from the clinical technology solutions company discuss how digital tools like eCOAs have been invaluable in facing pandemic-related challenges.

122

122

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?

Health and Personal Care Stores 138

Health and Personal Care Stores Medication Guidelines Communication 138

Pharma Times

JANUARY 28, 2021

Study suggests that palbociclib could be used to treat around a fifth of people with TNBC

144

144

Pharma Marketing Network

JANUARY 27, 2021

2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. Some Key Discussion Topics Include: What have we learned about how to create connection within this new paradigm? Which recent innovations are poised to become the best practices that will create measurable impact in 2021? Tune in to listen to the Pharma Marketing Network and leading experts from GSK, Otsuka & Bayer as we navigate these trends and discuss what you need to know to

98

98

pharmaphorum

JANUARY 29, 2021

JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety has achieved the opposite. The post-marketing safety study showed that Xeljanz (tofacitinib) – used to treat rheumatoid arthritis (RA) – was associated with a higher rate of heart attacks and cancer than a TNF inhibitor in patients aged over 50 with underlying cardiovascular risk factors.

Labelling 135

Labelling 135

Outsourcing Pharma

JANUARY 26, 2021

While the change signifies the life-sciences solutions firmâs commitment to help customers and patients, day-to-day functions will remain much the same.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

JANUARY 26, 2021

Lab tests evaluated vaccine's efficacy against UK and South African variants

Vaccines 139

Vaccines 139

Pharma Marketing Network

JANUARY 25, 2021

Pharma-Marketing is owned and operated by eHealthcare Solutions. The post PMN WEBINAR: Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience appeared first on Pharma Marketing Network.

97

97

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development.

Communication 123

Communication Drug Development 123

Outsourcing Pharma

JANUARY 26, 2021

With fewer than 3% of analyzed genomes currently coming from Africans, the companies are looking to increase access to and understanding of patient data.

98

98

Pharma Times

JANUARY 29, 2021

Datopotamab deruxtecan and Enhertu were evaluated in non-small cell lung cancer patients

123

123

NY Times

JANUARY 27, 2021

Spain has suspended vaccinations in Madrid because of a shortfall of doses, as the European Union locks horns with the drugmaker AstraZeneca over vaccine delivery cuts.

Vaccines 67

Vaccines Immunity Immunization 67

pharmaphorum

JANUARY 27, 2021

Back in 2017, the UK biotech RedX Pharma had to sell its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for $40 million. That drug, now known as LOXO-305 was one of the stars of the American Society of Haematology (ASH) conference in December, finding its way into Eli Lilly’s pipeline after the big pharma’s $8 billion takeover of Loxo.

Packaging 117

Packaging 117

Outsourcing Pharma

JANUARY 25, 2021

Conducted by SubjectWell, the survey of patients with Type 2 diabetes reveals how ethnicity and other factors play a part in trial participation tendencies.

Diabetes 98

Diabetes 98

Pharma Times

JANUARY 29, 2021

Speciality vaccine company has also started production of vaccine candidate

Vaccines 126

Vaccines 126

NY Times

JANUARY 26, 2021

As vaccine production falls behind schedule, and the European Union lags in inoculating people, Brussels and London are lobbing threats and accusations at each other.

Vaccines 60

Vaccines Immunity Immunization 60

pharmaphorum

JANUARY 26, 2021

Novartis has said that its investment in digital technology has helped it to ride out the worst of the pandemic, although sales of some of its newly-launched products have been affected by a fall in prescriptions and hospital visits. The big Swiss pharma still managed to grow sales in Q4 compared with the same period last year, with sales increasing a reported 3% to $12.8 billion and profits growing 2% to just over $3 billion.

Hospitals 105

Hospitals Immunity Immunization 105

Outsourcing Pharma

JANUARY 25, 2021

The agency has given the thumbs up to ViiVâs once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.

98

98

Pharma Times

JANUARY 28, 2021

The New Variant Assessment Platform will be led by Public Health England

127

127

NY Times

JANUARY 26, 2021

Scientists are exploring the physics of viruses, to understand how these pathogens assemble themselves — and might be rent apart.

Immunity 70

Immunity Immunization Vaccines 70

pharmaphorum

JANUARY 29, 2021

Novavax’s COVID-19 vaccine could be added to the UK’s growing arsenal of shots against the disease after it showed 89.3% efficacy in a late-stage trial. The shot is the first to show efficacy against the new variant found in the UK which accounted for around half of cases in the phase 3 study. Efficacy against the original COVID-19 strain was calculated at around 95.6%, falling to to around 85.6% against the UK variant strain, based on a post-hoc analysis.

Vaccines 104

Vaccines 104

Outsourcing Pharma

JANUARY 28, 2021

As the COVID-19 vaccines continue the early stages of circulation in the US, the agency keeps an eye on industry actions and offers advice to key players.

Vaccines 97

Vaccines 97

Pharma Times

JANUARY 26, 2021

Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis

120

120

Drug Patent Watch

JANUARY 28, 2021

Annual Drug Patent Expirations for UPNEEQ Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are four patents protecting this drug. This drug has…. The post New patent for Rvl Pharms drug UPNEEQ appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

JANUARY 28, 2021

New findings from a digital study have challenged the belief that stress is a significant factor in triggering migraine attacks. Results came from a study by the digital health firm Curelator and the University of Calgary, who found that only 7.1% of patients had a majority of their attacks associated with increased levels of perceived stress. At the same time 76% of the total number of migraine attacks were associated with either flat or decreasing levels of perceived stress.

Data Entry 104

Data Entry 104

Drug Channels

JANUARY 29, 2021

Today’s guest post comes from David Holladay, President of CoverMyMeds. David highlights the value of empathy in patient care. He also shares crucial findings from CoverMyMeds’ new 2021 Medication Access Report. This report provides a wealth of data about medication access, while also highlighting patients’ own stories and experiences. Read on for David’s insights.

52

52

Pharma Times

JANUARY 27, 2021

Cost-effectiveness agency initially turned down the drug in this setting

123

123

Drug Patent Watch

JANUARY 26, 2021

Annual Drug Patent Expirations for BRIDION Bridion is a drug marketed by Organon Sub Merck and is included in one NDA. It is available from one supplier. There are three…. The post New patent expiration for Organon Sub drug BRIDION appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

JANUARY 29, 2021

Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research. Researchers from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University analysed 2019 NHS dispensing data across the UK. The goal was to see how many patients are started on new prescriptions each year that could be potentially optimised by genetic testing.

Clinical Pharmacology 98

Clinical Pharmacology Community Pharmacies 98

Pharma in Brief

JANUARY 26, 2021

A defendant in a patent infringement action under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations was allowed to amend its defence to include invalidity allegations not found in the Notice of Allegation. Background. In an action under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ) concerning three patents, the defendant sought to amend its statement of defence to add new prior art references and invalidity allegations.

52

52

Pharma Times

JANUARY 29, 2021

Meanwhile, Phase IIb results from South Africa trial demonstrated 60% efficacy

Vaccines 112

Vaccines 112